Glucose sensors may help: their use is linked to fewer birth problems in women whose diabetes starts during pregnancy. A 2026 review in *Diabetes Therapy* brings together the growing evidence. It focuses on gestational diabetes, meaning diabetes that develops during pregnancy. These women did not have blood sugar problems before pregnancy. The review looks at continuous glucose monitoring, or CGM. These sensors track sugar levels throughout the day and night. Sensor use was linked to fewer babies growing larger than expected. It was also linked to fewer babies needing intensive care after birth. Women using sensors also had fewer Cesarean births, where babies are delivered through surgery. The source summary gives no figures for the size of these differences. These links are promising, but do not prove sensors alone caused better outcomes. The review also reports possible earlier detection of diabetes during pregnancy. That could allow blood sugar management to begin sooner. Sensors can help reveal daily and weekly patterns during and after pregnancy. For this community, Glucose Time-In-Range (CGM) is one measure the review explores. It shows how much time sugar levels stay within a chosen range. Other measures include average levels and time spent above or below that range. No specific sensor targets have been agreed on for gestational diabetes. That gap matters when members compare their own numbers. Sharing the range used alongside a percentage gives the community more context. Comparing daily and weekly reports can also keep the conversation focused on patterns, rather than one reading. The review supports learning from those trends, not treating one percentage as a proven goal for everyone. If you used a glucose sensor during pregnancy, what did your reports help you notice?